开立医疗: 第四届监事会第九次会议决议公告

Group 1 - The company held the ninth meeting of the fourth supervisory board, which was legally valid with all three supervisors present [1] - The supervisory board unanimously approved the 2025 Employee Stock Ownership Plan, confirming its compliance with relevant laws and regulations [2][3] - The board believes that the employee stock ownership plan will enhance corporate governance and create a balanced value distribution system, benefiting the company's sustainable development [2][3] Group 2 - The supervisory board also approved the 2025 Restricted Stock and Stock Option Incentive Plan, which aligns with legal requirements and aims to attract and retain talent [3][4] - The plan is designed to integrate the interests of shareholders, the company, and employees, promoting long-term development without harming the interests of the company and its shareholders [3][4] - The board confirmed that there are no prohibitive circumstances for implementing the incentive plan, and the company is qualified to proceed [3][4] Group 3 - The 2025 Incentive Plan Management Measures were approved to ensure the plan's smooth implementation and compliance with legal standards [4] - The assessment indicators for the incentive plan are deemed scientific and reasonable, aimed at achieving the plan's objectives and enhancing corporate governance [4] - The board will publicly disclose the list of incentive plan participants before the shareholders' meeting, ensuring transparency [6]